Abnormalities in the cAMP signaling pathway in post-mortem brain tissue from the Stanley Neuropathology Consortium

Brain Research Bulletin

Volumn 55, Issue 5, 2001, Pages 625-629

  Stewart, R Jay ^a   Chen, Biao ^a   Dowlatshahi, Dar ^a   MacQueen, Glenda M ^a   Young, L Trevor ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

BDNF; Bipolar disorder; cAMP signaling; CREB; Major depressive disorder

Indexed keywords

ADENYLATE CYCLASE; ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALMODULIN BINDING PROTEIN; CYCLIC AMP; PSYCHOTROPIC AGENT;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; AUTOPSY; BRAIN TISSUE; CLINICAL ARTICLE; DEPRESSION; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MANIC DEPRESSIVE PSYCHOSIS; MENTAL DISEASE; NEUROPATHOLOGY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SECOND MESSENGER; TEMPORAL CORTEX;

EID: 0035878170     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(01)00524-X     Document Type: Review

References (26)

1. Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder
2. Lithium and valproate differentially regulate brain regional expression of phosphorylated CREB and c-Fos
3. Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content
4. Adenylyl cyclase activity and G-protein subunit levels in post mortem frontal cortex of suicide victims
5. G Protein-coupled cyclic AMP signaling in post mortem brain of subjects with mood disorders; Effects of diagnosis, suicide, and treatment at the time of death
6. Increased temporal cortex CREB concentrations and antidepressant treatment in major depression
7. A molecular and cellular theory of depression
8. Increased cyclic AMP-dependent protein kinase activity in post mortem brain from patients with bipolar affective disorder
9. Receptor-mediated activation of G proteins is increased in post mortem brains of bipolar affective disorder subjects
10. Up-regulation of immunolabeled alpha2A-adrenoceptors, Gi coupling proteins, and regulatory receptor kinases in the prefrontal cortex of depressed suicides
11. Regulation of cyclic AMP-dependent protein phosphorylation in rat frontal cortex by chronic lithium; Identification of DARPP-32 and other lithium-regulated phosphoproteins
12. Mechanisms of action of antidepressant treatments; Implications for the etiology and treatment of depressive disorders
13. GTP gamma S and forskolin-stimulated adenylyl cyclase activity in post-mortem brain from depressed suicides and controls
14. Signal transduction pathways. Molecular targets for lithium's actions
15. Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients
16. High levels of Gs alpha in platelets of euthymic patients with bipolar affective disorder
17. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus
18. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments
19. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain
20. Abnormalities of cAMP signaling in affective disorders; Implications for pathophysiology and treatment
21. Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder
22. Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia
23. The catecholamine hypothesis of affective disorders; A review of supporting evidence
24. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells
25. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder
26. Post mortem cerebral cortex Gs alpha-subunit levels are elevated in bipolar affective disorder